| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 313 |
| 1 | METHOTREXATE SODIUM | 188 |
| 2 | ETANERCEPT | 184 |
| 3 | METHOTREXATE | 174 |
| 4 | LEFLUNOMIDE | 129 |
| 5 | INFLIXIMAB | 123 |
| 6 | TOCILIZUMAB | 115 |
| 7 | ABATACEPT | 111 |
| 8 | RITUXIMAB | 111 |
| 9 | HYDROXYCHLOROQUINE SULFATE | 103 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLORZOXAZONE | 8 | 0.0060 |
| 1 | ERGOCALCIFEROL | 95 | 0.0032 |
| 2 | INFLIXIMAB-DYYB | 9 | 0.0026 |
| 3 | SELENIUM | 9 | 0.0021 |
| 4 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 24 | 0.0020 |
| 5 | DEGARELIX | 7 | 0.0013 |
| 6 | LEFLUNOMIDE | 129 | 0.0012 |
| 7 | HYDROXYCHLOROQUINE SULFATE | 103 | 0.0011 |
| 8 | TOCILIZUMAB | 115 | 0.0010 |
| 9 | GOLIMUMAB | 10 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 231 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 214 |
| 2 | Corticosteroid [EPC] | 178 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 173 |
| 4 | Antirheumatic Agent [EPC] | 129 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 129 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 115 |
| 7 | Selective T Cell Costimulation Modulator [EPC] | 111 |
| 8 | Benzodiazepine [EPC] | 109 |
| 9 | Provitamin D2 Compound [EPC] | 95 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 22 | 0.0038 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 7 | 0.0034 |
| 3 | Provitamin D2 Compound [EPC] | 95 | 0.0032 |
| 4 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 5 | Interleukin-17A Antagonist [EPC] | 46 | 0.0012 |
| 6 | Antirheumatic Agent [EPC] | 129 | 0.0012 |
| 7 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 8 | alpha-Hydroxy Acid [EPC] | 2 | 0.0009 |
| 9 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |